Clinical Trials

Phase III Randomized Adjuvant Study of MK-3475 (Pembrolizumab) in Muscle Invasive and Locally Advanced Urothelial Carcinoma (AMBASSADOR) Versus Observation


Study ID
Alliance A031501

NCT Number
NCT03244384 (Click on the NCT number for more information about the trial)

Research Study Number
2017-0645

Principle Investigator
Dr. Robert Alter

Phase
III

Sponsor
Alliance


Other protocol defined inclusion/exclusion criteria could apply If you are a physician and would like more details about this study, please contact us at JTCCResearch@HackensackMeridian.org

Apply Now